Top Buy Stocks
Sign In
NASDAQ:ALDX
Aldeyra Therapeutics Stock Earnings Reports
$2.16
+0 (+0%)
At Close: May 16, 2025
Aldeyra Therapeutics Earnings Calls
Q1 2025
Beat
-$0.170 (32.00%)
| Release date | May 14, 2025 |
| EPS estimate | -$0.250 |
| EPS actual | -$0.170 |
| EPS Surprise | 32.00% |
| Revenue estimate | -666670 |
| Revenue actual | - |
Q4 2024
Missed
-$0.270 (-8.00%)
| Release date | Feb 28, 2025 |
| EPS estimate | -$0.250 |
| EPS actual | -$0.270 |
| EPS Surprise | -8.00% |
| Revenue estimate | - |
| Revenue actual | 244.526K |
Q3 2024
| Release date | Nov 07, 2024 |
| EPS estimate | -$0.250 |
| EPS actual | -$0.250 |
| Revenue estimate | 28.43M |
| Revenue actual | - |
Q2 2024
Missed
-$0.280 (-100.00%)
| Release date | Aug 01, 2024 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.280 |
| EPS Surprise | -100.00% |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Aldeyra Therapeutics
Below you can see how ALDX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q2 2024
Missed
| Release date | Aug 01, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $3.71 |
| EPS estimate | -$0.140 |
| EPS actual | -$0.280 |
| EPS surprise | -100.00% |
| Date | Price |
|---|---|
| Jul 26, 2024 | $4.15 |
| Jul 29, 2024 | $3.94 |
| Jul 30, 2024 | $3.95 |
| Jul 31, 2024 | $3.94 |
| Aug 01, 2024 | $3.71 |
| Aug 02, 2024 | $3.52 |
| Aug 05, 2024 | $3.23 |
| Aug 06, 2024 | $3.44 |
| Aug 07, 2024 | $3.26 |
| 4 days before | -10.60% |
| 4 days after | -12.13% |
| On release day | -5.12% |
| Change in period | -21.45% |
Q3 2024
| Release date | Nov 07, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $5.34 |
| EPS estimate | -$0.250 |
| EPS actual | -$0.250 |
| Date | Price |
|---|---|
| Nov 01, 2024 | $5.36 |
| Nov 04, 2024 | $5.18 |
| Nov 05, 2024 | $5.27 |
| Nov 06, 2024 | $5.40 |
| Nov 07, 2024 | $5.34 |
| Nov 08, 2024 | $5.52 |
| Nov 11, 2024 | $5.49 |
| Nov 12, 2024 | $4.76 |
| Nov 13, 2024 | $4.41 |
| 4 days before | -0.373% |
| 4 days after | -17.42% |
| On release day | 3.37% |
| Change in period | -17.72% |
Q4 2024
Missed
| Release date | Feb 28, 2025 |
| Fiscal end date | Dec 31, 2024 |
| Price on release | $5.11 |
| EPS estimate | -$0.250 |
| EPS actual | -$0.270 |
| EPS surprise | -8.00% |
| Date | Price |
|---|---|
| Feb 24, 2025 | $6.50 |
| Feb 25, 2025 | $6.50 |
| Feb 26, 2025 | $6.59 |
| Feb 27, 2025 | $6.34 |
| Feb 28, 2025 | $5.11 |
| Mar 03, 2025 | $6.06 |
| Mar 04, 2025 | $6.17 |
| Mar 05, 2025 | $6.15 |
| Mar 06, 2025 | $6.29 |
| 4 days before | -21.38% |
| 4 days after | 23.09% |
| On release day | 18.59% |
| Change in period | -3.23% |
Q1 2025
Beat
| Release date | May 14, 2025 |
| Fiscal end date | Mar 31, 2025 |
| Price on release | $2.17 |
| EPS estimate | -$0.250 |
| EPS actual | -$0.170 |
| EPS surprise | 32.00% |
| Date | Price |
|---|---|
| May 08, 2025 | $2.16 |
| May 09, 2025 | $2.18 |
| May 12, 2025 | $2.21 |
| May 13, 2025 | $2.08 |
| May 14, 2025 | $2.17 |
| May 15, 2025 | $2.16 |
| May 16, 2025 | $2.16 |
| 4 days before | 0.463% |
| 4 days after | -0.461% |
| On release day | -0.461% |
| Change in period | 0% |
Aldeyra Therapeutics Earnings History
Earnings Calendar
FAQ
When is the earnings report for ALDX?
Aldeyra Therapeutics (ALDX) has scheduled its earnings report for Aug 07, 2025 after the markets close.
What is the ALDX price-to-earnings (P/E) ratio?
ALDX P/E ratio as of May 16, 2025 (TTM) is -2.31.
What is the ALDX EPS forecast?
The forecasted EPS (Earnings Per Share) for Aldeyra Therapeutics (ALDX) for the first fiscal quarter 2025 is -$0.260.
What are Aldeyra Therapeutics's retained earnings?
On its balance sheet, Aldeyra Therapeutics reported retained earnings of $0 for the latest quarter ending Mar 31, 2025.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
